arrow
T

Takayuki Nakayama

Aichi Medical University
H指数:30
被引数:2,461

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ascophyllan Supplementation Is Safe and Associated with Exploratory Modulation of Innate Immune Phenotypes, Biochemical Parameters, and the Gut Microbiome in a Randomized Pilot Trial

Ascophyllan补充剂是安全的,并与初步调节固有免疫表型、生化参数及肠道微生物组相关:一项随机初步试验

2026-06-150
OA
Comparison of real-world outcomes between nivolumab plus ipilimumab and lenvatinib plus pembrolizumab or nivolumab plus cabozantinib combination therapies for previously untreated advanced renal cell carcinoma

比较纳武利尤单抗联合伊匹木单抗与乐伐替尼联合帕博利珠单抗或纳武利尤单抗联合卡博替尼联合疗法在既往未治疗的晚期肾细胞癌中的真实世界结局

2025-09-012
PRE
Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinoma

起始剂量酪氨酸激酶抑制剂对免疫检查点抑制剂联合酪氨酸激酶抑制剂治疗初治晚期肾细胞癌后结局的影响

2025-09-010
PRE
Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy
2024-02-290
OAAI
Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting

治疗前肿瘤免疫微环境预测新辅助化疗背景下肌层浸润性膀胱癌的临床反应和预后

2021-11-1518
OA
Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy
2020-12-304
OAAI
Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes
2020-12-180
OAAI
Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model
2020-09-1417
OAAI